The WHO

The Lancet

Volumn 382, Issue 9907, 2013, Pages 1778-1779

  Fast, Patricia E ^a   Price, Matt A ^b   Rida, Wasima N ^c   Kamali, Anatoli ^d  

^a INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^b Uganda Research Unit on AIDS ^*

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d Project San Francisco   (Rwanda)

Author keywords

[No Author keywords available]

Indexed keywords

AFRICA; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; VIRUS LOAD; WORLD HEALTH ORGANIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; NOTE; HIV INFECTIONS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84888598764     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)62539-8     Document Type: Letter

References (5)

1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach. June, 2013. Geneva: World health Organization, 2013. http://www.who.int/hiv/pub/guidelines/arv2013/download/en/index.html (accessed Aug 10, 2013).
2. Mayer K, Beyrer C. WHO's new HIV guidelines: opportunities and challenges. Lancet 2013; 382: 287-88.
3. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009; 373: 48-57.
4. Amornkul PN, Karita E, Kamali A, et al. Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa. AIDS 2013; published online Oct 9. DOI:10.1097/QAD.0000000000000012.
5. Karita E, Ketter N, Price MA, et al. CLSI-derived hematology and biochemistry reference intervals for healthy adults in Eastern and Southern Africa. PLoS One 2009; 4: e4401.